China Shineway Pharmaceutical Group Limited
Important Dates
China Shineway Pharmaceutical Group Ltd.'s next confirmed earnings release is scheduled for March 30, 2027.
| Earnings Date | 3/30/2027 |
Share Statistics
As of December 31, 2025, China Shineway Pharmaceutical Group Ltd. has 37.76M shares outstanding.
| Shares Outstanding | 37.76M |
Financial Position
As of December 31, 2025, China Shineway Pharmaceutical Group Ltd. maintains a current ratio of 3.71, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.71 |
| Quick Ratio | 3.01 |
| Debt / Equity | 4.15 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 3,021.00 |
Stock Price Statistics
As of the close on October 14, 2026, China Shineway Pharmaceutical Group Ltd.'s stock has declined approximately 12.78% over the past 52 weeks.
| 52-Week Price Change | -12.78% |
Balance Sheet
USDAs of December 31, 2025, China Shineway Pharmaceutical Group Ltd. holds 1.08B in cash and equivalents against 47.89M in total debt, resulting in a net debt position of -981.61M. Total book value stands at 1.15B, with working capital of 971.59M providing operational flexibility.
| Cash & Cash Equivalents | 1.08B |
| Total Debt | 47.89M |
| Net Debt | -981.61M |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 30.53 |
| Working Capital | 971.59M |